Top 50 Biotechnology Angel Investors in United States

Investor	Biotechnology United States investments
Milad Alucozai	15
Jaffray Woodriff	10
Kingsley Advani	9
Jeff Dean	9
Jude Gomila	9
bumpkins profile	8
Alice Zhang	7
Paul Buchheit	7
Zach Weinberg	6
Sahin Boydas	6
Wei Guo	6
Jeff Hammerbacher	6
Erik Peterson	5
Chris Gibson	5
Anne Wojcicki	5
Kevin Moore	5
Elad Gil	5
Jim Mellon	5
Brian Armstrong	5
David R. Walt	5
Farzad (Zod) Nazem	5
Evan Cheng	5
Daniel Curran	4
John D'Orazio	4
Bill Gates	4
Bill Gates	4
Eric Kwan	4
Todd Corenson	4
Esther Dyson	4
Cory Levy	4
Sam Altman	4
Max Levchin	4
Timothy A. Springer	4
Brenton Saunders	4
Peter Thiel	4
Ling Wong	4
Mark Cuban	4
Nat Turner	4
Bradley Horowitz	4
Jack Abraham	4
Brad Flora	4
David Beyer	4
Daren Cotter	4
Jeff Huber	3
Aaron Levie	3
Rayyan Islam	3
Benjamin Kong	3
Franklin Berger	3
Kirill Makharinsky	3
Tim Kendall	3

Dr. Milad Alucozai is an Afghan-American neuroscientist, entrepreneur, biotech executive, and global investor with nearly two decades of experience in deep tech, primarily in life sciences. He pushes the boundaries of bioengineering and computational advancements, integrating machine learning and artificial intelligence into biology and medicine.With a strong commitment to commercializing transformative technologies and fostering startup ecosystems worldwide, he is a thought leader and formal mentor for entrepreneurs through organizations like Creative Destruction Lab and the Wyss Institute at Harvard Medical School.Currently, Milad is the head of Bio and Deep Tech at BoxOne Ventures, where he spearheads the firm’s investments in early-stage companies with breakthrough scientific ideas. With nearly 80 early-stage investments, they are recognized as one of North America’s most active venture firms. He is also a Venture Partner at Entrepreneur First, a global fund that has built over 500 companies from scratch with an enterprise value of $10bn. He supports founders with strategy, scaling, business development, securing growth capital, and leadership training, often being their first investor and guiding them from startup inception to IPOs or acquisitions.He started his career in translational neuroscience and multiphysics laboratories before transitioning into founding roles at biotech startups. He is part of the founding team at Mekonos, a San Francisco-based company creating a proprietary cell-engineering platform to support the future of cell and gene therapies. He was also part of the founding team at Corstem, which specialized in machine learning and artificial intelligence software and was later acquired by Circle Cardiovascular, a platform in over 1000 hospitals and more than 40 countries. At Accenture, Milad directed teams of data scientists, designers, and engineers in developing artificial intelligence platforms for global pharmaceutical companies and hospital networks.Milad serves as a Fellow in Healthcare Engineering at the Regenstrief Center. In 2020, he served as an External Advisor to AstraZeneca. He was recognized as a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a degree in Neuroscience from Purdue University’s Honors Program. As a George J. Mitchell Scholar, he completed his master’s in Immunology and earned his doctorate from the Richard M. Fairbanks School of Public Health.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

Angel Investor located in Charlottesville, VA

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Angel
United States

Portfolio highlights

Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
Fringe — With 100+ vendors, Fringe offers an employee lifestyle benefits experience that builds loyalty, productivity, and well-being. Learn more to get started!
Starchive — AI enriched Digital Asset Management designed by creators for creators, to maximize the control and ownership of their content, community, and commerce in the Visual Media Economy.

Kingsley Advani is a British investor. He started investing in 2013, funding 50 companies, 4 funds and donating to non-profits including: SENS Foundation, Methuselah Foundation, Stanford University, National University of Singapore. He is particularly interested in regenerative medicine for age-related disease. Investments: Oisin, Turn Bio,Oncosenx, Monzo, Robinhood, Abra, Coinbase, Momentus, Demonpores, 64-x, Nectome. Investment areas: biotechnology, neurotechnology, longevity, space, fintech.

Investment focus

FinTech, Financial Services, Biotechnology
Seed, Pre-Seed, Series A
United States, Singapore, United Kingdom

Portfolio highlights

Checkstep — AI Content Moderation Services: learn how AI can help you scale your content moderation and keep your users and moderators safe.
Allocations — 10,000+ investors and fund managers build, onboard and close funds on Allocations - the fastest and most advanced fund platform in the world
Ashvattha Therapeutics — Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.

Jeff Dean joined Google in 1999 and is currently a Google Senior Fellow in Google's Research Group, where he leads the Google Brain team, Google's deep learning research team in Mountain View, working on systems for speech recognition, computer vision, language understanding, and various predictive tasks. He has co-designed /implemented five generations of Google's crawling, indexing, and query serving systems, and co-designed / implemented major pieces of Google's initial advertising and AdSense for Content systems. He is also a codesigner and coimplementor of Google's distributed computing infrastructure, including the MapReduce, BigTable and Spanner systems, protocol buffers, LevelDB, and TensorFlow, a popular open-source system for machine learning.Jeff received a Ph.D. in Computer Science from the University of Washington in 1996. He is a Fellow of the ACM, a member of the U.S. National Academy of Engineering and the American Academy of Arts and Sciences, and a recipient of the Mark Weiser Award and the ACM-Infosys Foundation Award in the Computing Sciences.

Investment focus

Artificial Intelligence, Biotechnology, Health Care
Seed, Series A, Series B
United States, Japan, United Kingdom

Portfolio highlights

Lutra AI — Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform.
Sakana AI — We are creating a new kind of foundation model based on nature-inspired intelligence.
DatologyAI — DatologyAI optimize training efficiency, maximize performance and reduce compute costs with expert curation.

Jude Gomila is currently CEO and Founder of the startup Golden.

Investment focus

Software, Biotechnology, Information Technology
Seed, Pre-Seed, Angel
United States, United Kingdom, Canada

Portfolio highlights

Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.
HockeyStack — HockeyStack is the only SaaS analytics tool that can natively integrate with your tech stack and unify your marketing, sales, revenue, and product data to uncover what drives revenue. Using HockeyStack, you can answer questions, such as the LTV of a campaign, churn rate of each marketing channel, or the exact MRR a blog post brings.
Gradia Health — Gradia is an integrated, concierge care platform designed for clinics to support patients with chronic conditions.

blah - teh software was teh busted and they didn't want to fix it or hire someone to fix it, odd folks, these.

Investment focus

Health Care, Biotechnology, Software
Seed, Series A, Pre-Seed
United States, Canada, India

Portfolio highlights

Sorare — Global Fantasy Football. Collect limited edition digital collectibles, Manage your team and earn prizes!
Hoth Intelligence — Hoth Intelligence home page. Space age surgical technology brought down to earth.
Floating Point Group — Floating Point Group is a trading platform provider offering innovative, industry-leading trade execution and settlement

CEO and Co-founder at Verge Genomics; Angel Investor in Tech-Enabled Bio

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, United Kingdom

Portfolio highlights

Encellin — Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
Character.ai — Meet AIs that feel alive. Chat with anyone, anywhere, anytime. Experience the power of super-intelligent chat bots that hear you, understand you, and remember you.
Perplexity AI — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Before co-founding Flatiron, Zach was Co-Founder, President and COO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Zach co-foundedEatNow.com which was privately acquired. An active angel investor, Zach has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Zach studied economics and entrepreneurship at The Wharton School at the University of Pennsylvania.

Investment focus

Health Care, Software, Medical
Seed, Series A, Series B
United States, Israel, Colombia

Portfolio highlights

Scoop — Thrive in a hybrid work environment with Scoop's solutions for Workplace Safety, Workplace Utilization, Team Coordination, Desk Management, and Commute.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes
Overwatch Research — Generate accurate in vivo study data as a part of your efficient, connected R&D.

Sahin Boydas is the Head of RemoteTeam at Gusto.

Investment focus

Software, Financial Services, FinTech
Seed, Series A, Series B
United States, Mexico, Spain

Portfolio highlights

Heyday AI — Manage all your social media messages in one place, including private messages and comments, with Hootsuite. Clean up your inbox with a free trial now!
Shield AI — AI pilots will revolutionize battlefields and commercial aviation at a scale greater than the self-driving movement reshaping our highways.
Wild Microbes — Wild Microbes is developing a microbial platform to produce faster and cheaper sustainable products from plastic to protein.

Wei Guo, the founding partner of UpHonest Capital, is an active angel investor in Silicon Valley, focusing on early-stage cross-sector investments. He founded Wei Fund in 2015 and UpHonest Capital Fund I in 2016, invested in well-known companies such as Hims&Hers(NYSE: HIMS), Vicarious Surgical(NYSE: RBOT), Knightscope (NASDAQ: KSCP), Checkr,Lime, Boom, Rescale, Dialpad and more. Since 2015, he has invested in over 400 Silicon Valley startups, over 76 companies with valuations greater than 100 million USD, and 23 portfolio companies that have successfully exited.

Investment focus

Software, Artificial Intelligence, Health Care
Seed, Series A, Angel
United States, China, Canada

Portfolio highlights

Golden — Golden is a developer of a self-constructing knowledge database used to accelerate discovery and education. The company uses and leverages human effort by using machine intelligence to make the process of gathering and communicating knowledge simpler.It combines a powerful search across several entities with fine-grain alerts to stay on top ofchanges, and semi-automatic research assistance for gaps in knowledge that enable people in organizations to stay current, understand and leverage the latest trends in their industry.
Playbook — Playbook gives creators the opportunity to build and grow a subscription business. Fans get an all-access pass to a curated health and wellness content.
Crossing — Crossing Media is a live broadcast e-commerce service company that builds awareness, engagement, and sales through live-stream shopping.

Jeff Hammerbacher - Partner & Co-Founder @ Techammer

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Series A, Angel
United States

Portfolio highlights

Vectara — SaaS
Modal Labs — Modal develops machine learning software to help run code in the cloud. The software enables users to run or deploy machine learning models, massively parallel compute jobs, task queues, web apps, and more. It also writes the code to launch hundreds of custom containers and runs scripts in the cloud faster than on the local machine.
Together AI — Together will enable researchers, developers & companies to leverage and improve artificial intelligence with an intuitive data, models & computation platform.

Erik Peterson is the Founder at DormTrader.

Investment focus

Software, Biotechnology, SaaS
Seed, Equity Crowdfunding, Series A
United States, Canada, Algeria

Portfolio highlights

Hideout — Hideout makes high-quality food that is available for delivery. Danielle Sobel established the company in Los Angeles, California.
Abalone Bio — Our Functional Antibody Selection Technology platform (FAST) taps into the potential of the body's biological activities, expanding the reach of antibody drugs.
Altay Therapeutics — Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for chronic inflammatory conditions. It is currently focused on finding curative therapies for fibrosis, NASH, and liver cancer. It develops novel small molecule drugs against transcriptional regulators that are validated drivers of disease. It wasfounded in 2019 and is headquartered in San Francisco, California.

Chris Gibson is the Co-Founder and CEO of Recursion (Recursion Pharmaceuticals). He previously worked at Cure HHT as a Member Board of Directors. Chris Gibson attended the University of Utah.

Investment focus

Biotechnology, Health Care, Life Science
Series A, Seed
United States, France, United Kingdom

Portfolio highlights

Noetik — Noetik is an AI-native biotechnology company. Our mission is to leverage advanced machine learning methods to discover and develop cancer immunotherapies.
Amenities Health — Amenities is the healthcare industry's leading Digital Front Door and patient loyalty platform. We help healthcare providers to acquire new patients and upgrade them to members. Our all-in-one patient app works with most modern EMRs to: 1) register new users into a full EMR account in <30 seconds with full identity verification and noduplicates, 2) help those patients find care options and book appointments with simple, conversion-optimized workflows, 3) seamlessly integrates key patient portal and 3rd party functions (i.e., video visits, secure messaging, test results, and billing), and 4) upgrade patients to members with custom experiences and services offerings (i.e., for Medicare Advantage, concierge memberships, direct-to-employer, or direct primary care patients)
Cradle — Design better proteins

Anne Wojcicki is the Co-Founder and CEO of 23andMe. She previously worked at Passport Capital as a Healthcare Analyst. Anne Wojcicki attended Yale University.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
United States, United Kingdom, Canada

Portfolio highlights

Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.
Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.

Kevin Moore has 10 years experience as an angel/opportunity investor and operator. Prior to that, he has over 15 years of progressive technology i-banking, corp dev, and CFO experience at startups and $Bn corporates.

Investment focus

Software, Health Care, E-Commerce
Seed, Pre-Seed, Angel
United States, India, Canada

Portfolio highlights

Redbird — Redbird is an operating system that empowers data driven teams to easily create custom applications that automate advanced analytics work in minutes, without writing code.
SilkChart — SilkChart helps growth teams improve campaigns based on what users are doing in product - without relying on expensive data scientists. We do this through a no code analytics tool that combines marketing and product usage data to identify which channels, audiences, and content maximize revenue growth.
Augmend — Record your screen. Capture knowledge. Scale your expertise and yourself. Record once, share forever.

Elad Gil is the Co-Founder of Color Genomics. He previously worked at Twitter as a Vice President. Elad Gil attended the Massachusetts Institute of Technology.

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Series A, Series B
United States, United Kingdom, Israel

Portfolio highlights

Succinct — The easiest way to discover, develop, and deploy ZK.
Fieldguide — Fieldguide is a workflow automation and collaboration software platform for audit, attestation, assurance, and advisory practices and firms.
Cognition — Cognition is an applied artificial intelligence lab that focuses on reasoning and code.

Jim Mellon is an international investor with interests in several industries. After leaving Oxford, where he studied PPE, (Philosophy, Politics and Economics) he worked in Asia and the United States for two fund management companies, GT and Thornton, before establishing his own business in 1991. His business operations include two components, alisted fund management company called Charlemagne Capital, and an Asian mining group, Regent Pacific.In addition, Mr. Mellon is Co-Chairman of West African Minerals Corporation and Regent Pacific Group. He is on the board of a number of public quoted companies, including Brazilian Gold Corporation, Charlemagne Capital Limited, Manx Financial Group, Plethora Solutions, Polo Resources, Port Erin Biophara Investments Limited, and the Speymill plc. He is the life tenant of a trust which owns the Burnbrae Group, which has substantial assets in the biotechnology, financial services, property, mining and leisure sectors. Mr. Mellon spends most of his time working on startup ideas and investing. His book, “Wake Up!” was published in 2005; his second book "10 Investments for the Ten Years Ahead" was published in 2008. In 2012, he co-wrote "Cracking the Code" which focuses on the biotechnology sector and how to profit from it. Mr. Mellon lives in the Isle of Man, Brussels and Ibiza and is an honorary fellow of Oriel College, Oxford.

Investment focus

Biotechnology, Health Care, Food and Beverage
Series A, Seed, Funding Round
United States, United Kingdom, Israel

Portfolio highlights

Voxia — Amy collects and analyzes information from all over the web and provides actionable insights about your leads, prospects and clients, all in one click.
Monaco Foundry — We are a team of Serial Entrepreneurs, former Senior Government Advisors and Fortune 500 Executives. A global venture accelerator that invests in early to mid-stage companies and their growth through a unique sweat equity model.
The Duppy Share — The Duppy Share Caribbean Rum is the best rum for cocktails, mixed drinks and rum gifts. Try all our rum recipes, from rum and ginger to dark rum punch.

Brian Armstrong is the CEO and Co-founder of Coinbase, the world’s leading digital currency exchange. As CEO, Mr. Armstrong is responsible for Coinbase’s retail and institutional arms and all products and services that are developed by both trading platforms. Mr. Armstrong co-founded Coinbase in June 2012, and since then, has been responsible forintroducing much of America and beyond to cryptocurrency. Mr. Armstrong has led the team, now at over 200 employees, through over $200M in funding from leading investors such as Andreessen Horowitz, IVP, USV, DFJ and NYSE. Since co-founding the company, Mr. Armstrong has led Coinbase to serve over 10M customers across 32 countries, providing custody for more than $10B in digital assets. Mr. Armstrong was listed as Fortune 40 under 40 and Recode 100 in 2017.Before founding Coinbase, Mr. Armstrong worked as a Software Engineer at Airbnb from 2011-2012 as part of the hospitality marketplace, focusing on fraud prevention. At the time, Airbnb was moving money between 190 countries, and Mr. Armstrong had a front row seat into global payment systems.Previously, he worked as a Developer for IBM and Consultant at Deloitte.Mr. Armstrong holds three degrees from Rice University: Bachelor’s of Computer Science, Bachelor’s of Economics, and a Master’s of Computer Science.

Investment focus

Payments, Financial Services, Banking
Seed, Series A, Series B
United States, Brazil

Portfolio highlights

Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Stark Bank — Stark Bank is a smart bank account that aids a technological advancement of a company. It is a financial technology that allows companies to expand their operations by allowing them to make extra transfers, payments, and charges.
Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

David is Professor in the Department of Pathology, Brigham and Women’s Hospital and Wyss Institute for Biologically Inspired Engineering, and is a Howard Hughes Medical Institute Professor. David is the Scientific Founder of Illumina Inc. and Quanterix Corp and has co-founded several other life sciences startups. David has published over 300peer-reviewed papers and has over 75 issued US patents. He has received numerous national and international awards and honors for his fundamental and applied work in the field of optical microwell arrays and single molecules including the American Chemical Society Kathryn C. Hach Award for Entrepreneurial Success, Ralph Adams Award in Bioanalytical Chemistry, the American Chemical Society Gustavus John Esselen Award, Analytical Chemistry Spectrochemical Analysis Award, the Pittsburgh Analytical Chemistry Award, and the ACS National Award for Creative Invention. He is a member of the National Academy of Engineering, the National Academy of Medicine, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Institute for Medical and Biological Engineering, and a Fellow of the National Academy of Inventors. He received a BS in Chemistry from the University of Michigan and a PhD in Chemical Biology from SUNY at Stony Brook, and did postdoctoral studies at MIT.

Investment focus

Biotechnology, Genetics, Life Science
Seed, Series A, Series B
United States

Portfolio highlights

Vizgen — The next generation of genomics, expanding the impact of spatial context and demonstrating the potential of in situ single-cell spatial genomics.
Stoicheia — Stoicheia is a nanotechnology company accelerating materials discovery by defining and expanding the materials genome. Using its proprietary lithography technology, Stoicheia has developed a way to create Megalibraries of nanomaterials on a chip. The company's technology also can be used to combine elements in new ways — already creatingstructures comprising up to seven elements.
Torus Biosystems — Torus Biosystems offers an apparatus for DNA testing for scientific and medical research purposes in the fields of consumer products, food for human beings or animals, hygienic and beauty care for human beings or animals, agriculture, horticulture, and forestry. The company was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Farzad (Zod) Nazem has been a prolific angel investor and advisor to tech startup companies since his retirement from Yahoo! in 2007. He has invested in more than 60 early stage companies, and sits on the boards of Hand Foundation, and The Nueva School. His area of investment is about two thirds Big Data and Cloud platforms, and one third Healthand Medical. He was the Executive Vice President of Engineering and Chief Technology Officer of Yahoo from 1996 to mid 2007. He helped acquire and integrate over 50 companies and managed over six thousand engineers representing half of the company's employees. Between 1985 and 1996, Mr. Nazem held various software development and management positions at Oracle Corporation culminating in his role as Vice President of Media and Web Server Division. His tenure at Oracle also included membership in the company's Product Division Management Committee, which set overall strategy for Oracle products. Previously, Mr. Nazem was recruited from California Polytechnic State University by Rolm Corporation to be a software engineer in the VLCBX division. At age 19, he earned a B.S. degree in Computer Science with highest honors.

Investment focus

Health Care, Analytics, Machine Learning
Seed, Series A, Series B
United States, Canada

Portfolio highlights

Emailage — Emailage is a developer of fraud prevention and identity verification technology used to make transactions easier and secure. The company provides multi-faceted predictive solutions with email at the core through key partnerships, proprietary data, and advanced machine-learning technology. It proprietary algorithms in order to provide real-timealerts of risky transactions and delivers a risk score and enable companies to realize significant savings from identifying and stopping fraudulent transactions and improve customer experience.
Ceevra, Inc. — Ceevra is an advanced 3D visualization technology for surgeons. Using AI and other innovative computing techniques, Ceevra generates brilliant 3D digital models from standard CT scans and MRIs. Surgeons use the Ceevra 3D models to help educate and counsel patients, to decide on the best surgical approach, and to gain important insights whileoperating.
TigerGraph — TigerGraph is the fastest and only scalable graph database for the enterprise. Unleash the power and speed of our graph analytics platform today.

Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.

Investment focus

Software, Artificial Intelligence, Biotechnology
Seed, Funding Round, Pre-Seed
United States, United Kingdom, Australia

Portfolio highlights

PARSIQ — Explore the future of blockchain with PARSIQ - Your gateway to advanced blockchain monitoring, smart triggers, and real-time intelligence. Empower your crypto journey with cutting-edge technology and unparalleled insights. Join us in revolutionizing the way you interact with the blockchain ecosystem
Verida — The Verida Wallet is a mobile application that allows you to manage your decentralized identity and personal data. It provides a user-friendly interface for interacting with applications built on the Verida network.
Kernal Biologics — Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA

Daniel Curran is the Founder and CEO at CustEx.com.

Investment focus

E-Commerce, Software, Mobile
Seed, Series A, Funding Round
United States, Brazil, Canada

Portfolio highlights

CARD.com — Fully featured bank account with optional overdraft protection and round up savings account. Get your paycheck up to 2 days earlier.
RentoMojo — RentoMojo is an online furniture rental platform that was incorporated in November 2014.It currently operates in Bangalore, Pune, Mumbai, Hyderabad, Chennai, Delhi, Gurgaon and Noida.RentoMojo was founded by Geetansh Bamania, an ex-IITM, in November 2014 in India. Like many other young working professionals, he was living in rented apartments,working long hours and found it inconvenient to equip the house with furniture when he moved. RentoMojo was developed to provide an alternative to buying and selling furniture in rental properties.
GC Plus — Find Your Next Home Service Expert With Ease

John is the Founder and CEO of Capture Collective.

Investment focus

Biotechnology, Medical, Health Care
Seed, Funding Round, Equity Crowdfunding
United States

Portfolio highlights

RenovoDerm — A medical device company building a line of wound care products that provide a structure for tissue growth and promote faster healing of wounds—while reducing scar tissue. Funding prior to formation: $1.6 million.
Vascular Genesis — A medical device company laying the foundation for vascular conduit replacement with its line of cell-free, synthetic scaffold products -- with self-healing capabilities that lower the risk of rejection, infection, and stenosis. Funding prior to formation: $2.5 million.
Atreon Orthopedics — A medical device company building a line of orthopedic products that provide a structure for tissue growth and healing of sports medicine injuries including tendon ruptures/tears.

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Investment focus

Energy, Biotechnology, Manufacturing
Series C, Series A, Series B
United States, Canada, Israel

Portfolio highlights

Mainspring Energy — Mainspring Energy is engineering advanced technology to revolutionize the way electricity is generated and delivered
Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
Inflection AI — We are an AI studio creating a personal AI for everyone.

Bill Gates is the Co-chair of Bill and Melinda Gates Foundation. He attended Harvard University.

Investment focus

Energy, Biotechnology, Manufacturing
Series A, Series C, Series B
United States, Canada, Israel

Portfolio highlights

Mainspring Energy — Mainspring Energy is engineering advanced technology to revolutionize the way electricity is generated and delivered
Heineken — Welcome to the global website for Heineken International. Find information about our company, history, brands, strategy and careers here.
Inflection AI — We are an AI studio creating a personal AI for everyone.

Eric Kwan - Co-Founder & Managing Partner @ Locus Ventures

Investment focus

Software, FinTech, E-Commerce
Seed, Pre-Seed, Funding Round
United States, India, Canada

Portfolio highlights

Treinta — Treinta is a digital ledger app for Latin American microbusinesses. Through Treinta, users can easily record transactions by assigning products from their inventory and see how their business metrics evolve in real time. The app helps owners save up to 30 minutes a day in bookkeeping related tasks and improve efficiency by over 30%. Out of the 50million microbusinesses in LATAM, today 90% still track their sales and expenses by using pen and paper.
Ferveret — Ferveret develops liquid cooling technology for data centers and other infrastructure. Our company is backed by Y Combinator and MIT Media Lab's E14.
Kriya AI is now Kalendar AI — Kalendar AI books new revenue on autopilot

Todd Corenson - Founder @ Enlon

Investment focus

Biotechnology, FinTech, SaaS
Seed, Pre-Seed, Convertible Note
United States

Portfolio highlights

Solugen — Solugen's mission is to decarbonize the chemicals industry. Solugen combines synthetic biology with metal catalysis to make carbon negative chemicals at scale.Solugen's patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with thecompetition.
HelixNano — Helix Nanotechnologies uses artificial intelligence to help cure genetic diseases. HelixNano is a Y Combinator and venture backed biotech startup. At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. We’re moving fast but thinking long-term. We’re alreadytesting COVID-19 vaccine candidates designed to be precise and safe. Our next goal is to create a vaccine that protects everyone not only from this virus, but all future coronaviruses.
iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.

Esther Dyson - Founder @ Way to Wellville

Investment focus

Health Care, Software, Medical
Seed, Series A, Funding Round
United States, Canada, Russian Federation

Portfolio highlights

Ezra AI — Ezra provides full-body MRI screening for potential early cancer and abnormalities in up to 13 organs. Book a scan today.
Boxhub — Buy new & used shipping containers with Boxhub. We make buying a shipping & storage containers easy - get it delivered right to your door. Shop today!
Way — Way combines intuitive eating with behavior science for mindful habits. 73.5% of app users report transformed thinking post-program.

Cory Levy is the Founder Advisor of Humaning.

Investment focus

Software, Artificial Intelligence, Blockchain
Pre-Seed, Seed, Grant
United States, United Kingdom

Portfolio highlights

Swsh — Swsh is a social app that aims to strengthen true friendships rather than superficial relationships with followers.
Fun — Fun offers to build a product ecosystem that leverages cross-chain decentralized wallets on the Odsy blockchain.
Tab — Wearable AI companion.

Sam Altman is a Partner of Apollo Projects. He previously worked at OpenAI as a Co-Founder and CEO. Sam Altman attended Stanford University.

Investment focus

Software, Internet, Artificial Intelligence
Seed, Series A, Series B
United States, Canada, Ghana

Portfolio highlights

Lyso — Lyso is a software that fully automates the checkout process within milliseconds on retail websites. It currently supports over 1,000 retail sites, including popular ones such as Best Buy, Newegg, Amazon, eBay, Walmart, and Target.
Meter — Meter provides internet infrastructure for businesses. Its full-stack approach combines hardware, software, and operations so that any company can seamlessly run on a reliable and modern network. Its goal is to make secure enterprise-grade networks more accessible, and to help innovative organizations get and stay online seamlessly. Fullstacksambition is to turn Meter’s infrastructure into a turnkey utility––when a company moves into any commercial space, the internet and WiFi just works.
Software Applications Incorporated — Rethinking the personal computing experience

Max Levchin is the Founder and CEO of Affirm. He previously worked at the Consumer Financial Protection Bureau as an Advisory Board Member. Max Levchin attended the University of Illinois Urbana-Champaign.

Investment focus

FinTech, Financial Services, Internet
Seed, Series A, Series B
United States, United Kingdom, India

Portfolio highlights

withco — You deserve to own your business' real estate. We help make that happen through a new concept: lease-to-own your commercial real estate.
CoPilot — CoPilot is pioneering Assisted Commerce for big-ticket purchases – starting with cars. You are the one spending the money - shouldn't you have an expert on your side? We founded CoPilot to make that a reality. For the average car buyer, who is not a car expert or enthusiast, car shopping can be a time consuming, frustrating process that leavespeople feeling alone and disadvantaged. CoPilot is changing this dynamic. Like a trusted friend who is knowledgeable about cars, knows where to look and what to buy, CoPilot provides car shoppers with an expert partner who empowers them to discover the perfect car at the best possible price with ease and confidence.
Black Ore Technologies — Black Ore's Tax Autopilot is the first AI tax platform for CPAs, offering complete 1040 tax preparation automation to tax professionals, so they can focus on growing their firm.

Timothy Springer is an internationally recognized leader in structural biology and immunology. With over 500 peer-reviewed publications that have received over 90,000 citations, he is one of the most highly cited scientists in any field. Timothy Springer received his Ph.D. from Harvard University in 1976, and subsequent post-doctoral training withDr. Cesar Milstein in Cambridge, UK. Timothy Springer has been elected to the National Academy of Sciences and to the American Academy of Arts and Sciences. Among numerous awards and honors, Timothy Springer is a recipient of the Royal Society of Medicine Medal, the William B. Coley Medal from the Cancer Research Institute, and the Crafoord Prize from the Swedish Academy of Sciences. Timothy Springer's research laid the foundation for a new class of pharmaceuticals, the selective adhesion molecule inhibitors, which include the approved drugs, alefacept, efalizumab, and natalizumab. Timothy Springer was the Founder of LeukoSite, a biotechnology company acquired by Millennium Pharmaceuticals in 1999. LeukoSite developed therapeutics for inflammatory, autoimmune, and cancer applications, including FDA-approved Campath™.

Investment focus

Biotechnology, Medical, Health Care
Series A, Series B, Seed
United States, Canada

Portfolio highlights

Prenuvo — Changing the medical paradigm from sick care to proactive healthcare
Seismic Therapeutic — Seismic Therapeutic is a biotechnology company integrating machine learning across the entire biologics discovery process to accelerate immunology drug development. Using its IMPACT™ platform, the company is addressing the central challenges of biologics discovery and development by fully integrating machine learning with the key elements ofbiologics drug discovery – structural biology, protein engineering, and translational immunology – to create optimized therapies on an accelerated path to patients. Seismic Therapeutic has an emerging pipeline of novel biologics to address adaptive immune system dysregulation to treat autoimmune diseases.
Tectonic Therapeutic — Tectonic, co-founded by Andrew Kruse and Tim Springer of Harvard Medical School, is transforming the discovery of antibodies and other biologic drugs targeting G-protein Coupled Receptors (GPCRs).

Brenton Saunders is the current Chief Executive Officer of Bausch & Lomb. He previously worked at The Allergan Foundation as a Chairman. Brenton Saunders attended Temple University’s Fox School of Business.

Investment focus

Health Care, Medical, Biotechnology
Seed, Series A, Series B
United States

Portfolio highlights

Wondermind — Welcome to Wondermind, your home for approachable, expert-backed mental health content you can actually use.
Nucleus — Nucleus provides genetic analysis of greater breadth, depth, and beauty. Users can upload their genetic information obtained through an established company. The proprietary algorithms will calculate polygenic risk scores and measure disease risk based on analysis of genetic variants and display them in a user-friendly platform.
Lipidio Pharmaceuticals — Lipidio Pharmaceuticals is a healthcare company that focuses on advancing a molecule to treat diseases associated with excess body fat. It includes non-alcoholic steatohepatitis, Prader-Willi syndrome, and antipsychotic drug-induced weight gain. The company was founded in 2018 and headquartered in San Diego, California.

Peter Thiel Is the Managing Partner of The Founders Fund. He previously worked at Stanford Law School as a Visitor. Peter Thiel attended Stanford University.

Investment focus

Software, FinTech, Financial Services
Series A, Seed, Series B
United States, Germany, Canada

Portfolio highlights

Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Enhanced Games — Enhanced Games Home
Alias Technologies — Here at Alias Technologies our goal is to help organizations tackle complex IT goals and initiatives in an ever-changing landscape. Leveraging our Partner relationships and extensive experience we are able to help position our customers for the future.

Dr. Ling Wong is Founder and General Partner of Highbury Group and Sea Lane Ventures. She also serves as Senior Advisor to Lightspeed Venture Partners. Highbury Group was founded on the principle to be a true partner and champion to entrepreneurs, using science and technology to build companies that fundamentally transform the world for thebetterment of humanity today, and in the future.Dr. Wong draws from her unique background and experience as a scientist, entrepreneur, and investor to support and bring to market companies that exist at the intersection between health and technology. “I love to partner with mission-oriented founders working on transformational ideas that can have a positive, lasting impact on society – and do so by leveraging technology and science in a financially sustainable manner,” said Dr. Wong.Prior to Highbury, she served at the Gates Foundation where she helped to establish a $1.5B global investment portfolio and created a $200M early stage program to support early stage entrepreneurs in more than 60 countries.As a health and technology investor, Dr. Wong has been involved in some of the market’s most significant investments and exits. She has partnered with over fifteen $1B+ companies, including: Devoted Health, Orca Bio, Collective Health, Color, Apeel, Shape, Stripe, Offer Up, Rappi, Branch Metrics, Notion, Modern Animal, Wheel and Satellite Bio. Notable exits include: Anacor Pharmaceuticals (acquired by Pfizer for $5.2B), Genocea Biosciences (NASDAQ: GNCA), Visterra (acquired for $430M), Slack (NYSE: WORK), Guardant Health (NASDAQ: GH), and recently Singular Genomics (NASDAQ: OMIC).Dr. Wong holds a PhD from Harvard in Engineering Sciences, a BSc in Chemical Engineering and BSc in Biology from MIT. During her time at Harvard, she created the world’s first inhaled TB vaccine. Her scientific training has shaped how she assesses financial opportunities, both to create value and to benefit human health. Dr. Wong has always been passionate about seeking entrepreneurs and partners that are looking to disrupt the status quo in science and technology for the betterment of society.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
United States, Colombia

Portfolio highlights

Satellite Bio — Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering. It focuses on the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions that can transform the lives of millions of patients who suffer from serious diseases.
Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
Shape Therapeutics — Shape Therapeutics (ShapeTX) is a biotechnology company with an end-to-end approach to RNA Gene Therapy, potentially enabling the development of cures in neurodegenerative, metabolic and rare genetic diseases through our breakthrough payload, delivery, and manufacturing platform technologies. Our vision is to facilitate adoption of thesetechnologies throughout the industry to develop effective treatments for as many patients as possible.

Mark Cuban is the founder of Fireside, Chairman and Founding Partner of AXS TV, and the Owner of Dallas Mavericks. He previously worked at Broadcast.com as a Co-Founder. Mark Cuban attended the Indiana University Bloomington.

Investment focus

Software, Artificial Intelligence, Blockchain
Seed, Series A, Angel
United States, United Kingdom, Canada

Portfolio highlights

Bot-It — Online automation for everyone. Let Bot-It automatically complete your online tasks.
Allstar — Allstar is a gaming company that believes every gamer can become a content creator, with the right tools. The company is driven by its mission is to make the everyday gamer the star of their greatest esports moments through technology that enables them to effortlessly create, discover, and share their own professional quality esports highlights.
Glove Wrap — Glove Wrap is a latex-free, thermoplastic elastomer band with the precise thickness, width, and length required to break in and shape your complete baseball glove while making the ideal pocket. Wrapping your glove with Glove Wrap applies pressure to the glove, reshaping it for easy use.

Before co-founding Flatiron, Nat was Co-Founder and CEO of Invite Media, an advertising technology company based in NYC. Invite Media built the industry's first enterprise advertising platform for buying and optimizing online media in real-time. Invite Media was acquired by Google in 2010. Prior to Invite Media, Nat started numerousinternet companies and also worked at Say Media and First Round Capital. An active angel investor, Nat has invested in over 30 technology startups throughout the country, including Bell Biosystems, Breakthrough, Care at Hand, DocPhin, Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics. Nat earned a Bachelor of Science degree cum laude in Economics with concentrations in Entrepreneurship and Marketing from The Wharton School of the University of Pennsylvania. In his spare time, Nat is an avid golfer and tries to trick trout with fake bugs.

Investment focus

Health Care, Software, Medical
Seed, Series A, Series B
United States, China, Colombia

Portfolio highlights

CollX — Snap photos of them and instantly get the current market price. Add them to your collection and track your overall portfolio value.
Collectors — Helping collectors to pursue their passion.
Iterative Scopes — Iterative Scopes provides gastroenterologists with machine learning-powered diagnostic tools that help them prevent colon cancer and improve patient outcomes

Bradley Horowitz is an Advisor and Vice President of Product Management at Google. Most recently he helped create Area 120, Google's incubator for internally-sourced innovation. He's led a large number of products, programs and initiatives at Google - including Google for Startups, Google Photos, Gmail, Google Voice, blogger, and GoogleNews.Before joining Google in February 2008, Horowitz was Yahoo's vice president of Advanced Development where he drove the acquisitions of Flickr and MyBlogLog, launched the Brickhouse incubator and developed new products like Yahoo! Pipes. Additionally, he was responsible for the company's initiative to open up its platform which included overseeing the Yahoo Developer Network (YDN).Previously, he was co-founder and CTO of Virage, where he oversaw the technical direction of the company from its founding through its IPO and eventual acquisition by Autonomy.Horowitz was a PhD candidate at the MIT Media Lab. While at the Media Lab, he worked on a number of topics related to computer vision, graphics and image processing, which resulted in a patented new technique for the recovery of structure, motion and camera parameters from video sequences.Horowitz holds an MS in Media Science from MIT and a BS in Computer Science from the University of Michigan.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
United States, United Kingdom, Germany

Portfolio highlights

CUR8 — CUR8 is committed to establishing a global market for carbon reduction. Carbon removal methods include increased rock weathering, direct air capture, forests, construction, soil, biomass, oceans, and new technologies.
Mill — Meet the cleanest, easiest way to prevent food waste at home. Mill recycles your peels, bones, stalks, and forgotten leftovers.
Parcha AI — Parcha is an AI-powered enterprise software that enables businesses to automate their scale compliance and operations.

Jack Abraham is the Founder and Managing Partner of Atomic. He previously worked at TalkIQ as a Co-founder and Investor. Jack Abraham attended The Wharton School.

Investment focus

Health Care, Financial Services, Biotechnology
Seed, Series A, Series B
United States

Portfolio highlights

Dispatch — OneAdvisory helps independent financial advisors to build ideal firms through strategic investments and advanced technology. The company was founded in 2022 and is headquartered in Miami, Florida.
JustPaid — Stay in control of your business with payments, AI-powered automation, benchmarking, contract tracking, opportunity alerts, and more, all in one platform.
Software Applications Incorporated — Rethinking the personal computing experience

Brad Flora is a Visiting Partner at Y Combinator. He is a former Co-Founder and CEO of Perfect Audience. Mr. Flora received a BA from Princeton University in English and an MS in Journalism from Northwestern.

Investment focus

Software, FinTech, Financial Services
Seed, Pre-Seed, Series A
United States, Mexico, India

Portfolio highlights

SWAP — Swap empowers companies to transform their financial operation with an innovative approach, technology, and business model. SWAP’s APIs offer clients end-to-end, white-label, financial solutions. Connected to them, its clients are able to develop complete financial ecosystems including pre-paid cards, digital wallets, financial services and furthermonetize their platform while expanding their core experience. It removes barriers and generates new business lines for companies, effectively creating internal fintech.
Wallet.ng — Wallet.ng is a fintech startup that allows people and companies to send, receive, and make payments, using their phone numbers.The company's infrastructure also provides plugins and libraries for merchants to accept payments online with just a URL. Wallet.ng users can pay directly into bank accounts and Pay Utility Bills in Nigeria.Wallet.ng is a mobile payment solution, its core infrastructure is built using technologies which is adaptable for multiple countries across Africa.It was established in Lagos, Lagos by John Oluranti Oke and Joseph Benson-Aruna in 2018..
Wallets Africa — Wallets Africa helps Africans and African-owned businesses send money, receive money, make card payments, and access overdrafts.

David is a Partner of Amplify Partners and co-founder of Chartio.com.Before joining Amplify Partners, David spent time as both a venture-backed entrepreneur and an early-stage investor. He began his career in technology as the co-founder and CEO of Chartio.com, a pioneering provider of cloud-based data visualization and analytics. He wassubsequently part of the founding team at Patients Know Best, one of the world’s leading cloud-based personal health record companies. David has been a prolific investor and advisor to entrepreneurs. He has personally invested in more than 50 early-stage companies, including Zymergen, Skycatch, Caribou Biosciences, Rigetti Computing, Casetext, Ginkgo Bioworks, Function of Beauty, Cruise Automation, and Bugcrowd. In addition, he currently serves on the advisory council of Bayes Impact, a nonprofit organization that deploys data science to solve important social challenges.He attended Brown University.

Investment focus

Software, Artificial Intelligence, Enterprise Software
Seed, Series A, Angel
United States

Portfolio highlights

Airtable — Airtable is a cloud-based software company that offers an easy-to-use online platform for creating and sharing relational databases.It brings the database out of the realm of power users and into the mainstream, creating a new type of flexible but sophisticated productivity tool that anyone can use. Airtable gives end-users the ability to createand share their own workflows for everything from managing an editorial calendar to planning a major event. The platform helps create flexible checklists, organize collections or ideas, and manage customers or contacts as well as offers a variety of templates ranging from home improvement to store inventory, enabling users to build custom applications without any prior coding experience.The company was founded by Andrew Ofstad, Emmett Nicholas, and Howie Liu in 2013 and is headquartered in San Francisco, California.
Astranis — Four billion people still have no internet access. Astranis is here to change that. We're making small satellites for geostationary orbit, recently signed a contract to triple the satellite internet capacity of Alaska, and raised our Series A from Andreessen Horowitz.
Ginkgo Bioworks — Ginkgo Bioworks is a biotechnology firm. It is a developer of biological engineering products and custom microbes across multiple markets. It designs, engineer, develops, tests, and licenses organisms. It discovers molecules in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. It also provides probiotic bacteria toprotect the body from dangerous infections, and it generates libraries of molecules. It serves cultured ingredients, carbon mitigation, probiotics, and natural product discovery markets.

Daren was the Founder and CEO of InboxDollars, an online marketing company that connects consumers and advertisers in a way that benefits both. He founded the company as a Freshman in college in 2000 and bootstrapped the company to more than $25 million in annual revenues. InboxDollars was acquired by Prodege in 2019. Daren is active in the MNstart-up community as an investor, advisor and mentor.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Funding Round
United States

Portfolio highlights

TicketRev — TicketRev helps fans find cheaper tickets to their favorite games and concerts. Fans name their price for their preferred seating location, enabling resellers and teams to sell their inventory faster.
Fulcrum — Designed with technology in mind, be free of paper with Fulcrum, the manufacturing ERP of the future. Ai scheduling, visual BOM, live tracking
Refr Sports — Refr Sports is developing a platform solution to fix inefficiencies and shortages in the United States referee marketplace by bringing new generation technologies and employees to the industry. Sports referees currently rely on antiquated third-party referee schedulers to provide them with games to work. Similarly, sports organizations rely on thesame referee schedulers to provide referees that are qualified to officiate their games. This approach has not been updated in decades as the referee industry continues to use outdated technologies and employment methods. The result has been a severe drop in the supply of referees while at the same time demand has increased.Our application, Refr Sports, will modernize the current system, providing referees and sports coordinators an efficient and effective tool for completing their respective duties. Refr Sports makes this a reality by offering a mobile application that supports both referees and sports organizers as end users. Our app delivers complete freedom to the users by allowing the sports organizations to post their game schedules along with officiating needs and offered compensation for each game. Referees can then see the ‘work order’, accept it, and be paid immediately after the game. The Refr platform makes money by taking a small service and processing fee on the payments we facilitate through the app. This business model is very similar to what has been successful in the food (DoorDash), transportation (Uber) and personal care (care.com) industries.Our Refr Team, made up of business, technical and sporting experience, has set out on a mission to create the platform that will turn the referee industry into a gig economy marketplace. The world has seen this successfully materialize in many industries already and the referee industry can be next, by making it easy to post opportunities, claim opportunities, and get paid.

Jeff Huber is the Founding CEO and Vice Chairman of GRAIL (2016-present). GRAIL's mission is to detect cancer early, when it can be cured.Prior to GRAIL, Jeff was a Senior Vice President at Google. Over 13 years at Google, Jeff co-founded Google's life sciences efforts in Google[x] (2013-2016), and led development and scaling for GoogleMaps (2011-2013), Google Apps (2005-2010), and Google Ads (2003-2011). During his tenure as an executive at Google, Jeff oversaw 50x growth in revenues (from $1 billion to >$50 billion) and organization (1,000 to >50,000 employees), and managed a $5 billion P&L and large distributed teams (5,000+ direct-line employees). Earlier, Jeff was vice president of architecture and systems development at eBay and senior vice president of engineering at Excite@Home, where he led consumer product and infrastructure development.Jeff was recognized as one of the ‘100 Most Intriguing Entrepreneurs’ (2017), and is an active early-stage investor/advisor in breakthrough life sciences and technology companies, including Openwater, Mammoth Biosciences, Vir, Sana, Zymergen, Atomwise, Genalyte, Pinterest, Honor, OpenDoor, and AngelList.Jeff holds a bachelor's degree in computer engineering from the University of Illinois, where he was Commencement Speaker (2016) and received a 'Distinguished Alumni Award' from the College of Electrical & Computer Engineering (2018) for 'challenging the status quo through innovation'. He also holds a master's degree in business from Harvard University. Jeff is a board member of GRAIL (Vice Chairman), Genalyte (Chairman), Electronic Arts (EA), Openwater, and The Exploratorium, and a former board member of Illumina (ILMN; 2014-2016).

Investment focus

Biotechnology, Health Care, Computer
Seed, Series A, Pre-Seed
United States, India

Portfolio highlights

Synapticure — The era of personalized care is finally coming to ALS. Synapticure will give all ALS patients access to the best care while fueling the advancement of personalized treatments for every type of ALS.
iMicrobes — We are a synthetic biology company on the mission to work with the world's largest companies to use new raw materials and recycle waste for chemical production, polymers, agriculture, and space exploration.
Mammoth Biosciences — Reading and writing the code of life.

Aaron Levie is Chief Executive Officer, Cofounder and Chairman at Box, which he launched in 2005 with CFO and cofounder Dylan Smith. He is the visionary behind the Box product and platform strategy, incorporating the best of secure content collaboration with an intuitive user experience suited to the way people work today. Aaron leads the companyin its mission to transform the way people and businesses work so they can achieve their greatest ambitions. He has served on the Board of Directors since April 2005.Aaron attended the University of Southern California from 2003 to 2005 before leaving to found Box.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Series B
United States

Portfolio highlights

Socket — Socket fights vulnerabilities and provides visibility, defense-in-depth, and proactive supply chain protection for JavaScript, Python, and Go dependencies.
BoomPop — Work culture resources, virtual event inspiration, team building ideas, and fresh perspectives on the future work, brought to you by the BoomPop team.
Superblocks — Superblocks is the fast, easy and secure way for developers to build custom internal tools fast. Connect your databases & APIs. Drag and drop UI components. Extend with Python or Javascript. Deploy in 1-click. Secure and Monitor using your favorite tools

Rayyan Islam is the Co-Founder and General Partner at 8090 Industries. As serial entrepreneur, investor and advisor focused on industrial technology and the low-carbon economy, the companies Rayyan's invested in, sourced and advised have grown to over $8B in market value and have gone to raise further financing from the likes of SequoiaCapital, Union Square Ventures, Lux Capital, Andreessen Horowitz, Venrock, Khosla Ventures and Bill Gates's Breakthrough Energy Ventures. Rayyan previously spent time helping source technology investments for multiple family offices globally, particularly focused towards industrialists based in the Texas and American midwest region and began his VC career at leading East Coast seed stage venture firm, Romulus Capital, where he sourced the firm’s most valued investment, EquipmentShare.A product manager by trade, he worked stints at Spotify, was on the founding team of a subscription airline and began his career supporting M&A transactions for industrial clients at Deloitte as well as economic developments efforts for Deloitte Consulting’s Emerging Markets Practice. Rayyan is a Forbes 30U30 Fellow, served as a United Nations Youth Delegate and is a recipient of the Outstanding Youth Delegate Award.Influenced by his family upbringing in Bangladesh, he personally witnessed energy security issues and the ramifications of climate change at a young age and its impact on communities around the world. Determined to make a serious dent on the issue, Rayyan supports a cadre of climate solutions, drafted policy recommendations to President Joe Biden’s climate transition team and is the editor of Decarbon Weekly, a decarbonization focused newsletter which counts leading climate scientists, members of state and local governments, climate tech founders and ESG focused investors and foundations amongst its subscription base. Rayyan co-founded the industrial decarbonization fund at 8090 Partners, in partnership with prominent industrial and energy families from around the world to invest, support and accelerate breakthrough technology companies decarbonizing every industrial sector driven by radical economic advantages.Rayyan and his work has been featured on Bloomberg, Yahoo Finance, Huffington Post and Forbes.

Investment focus

Renewable Energy, Biotechnology, Energy
Seed, Series A, Funding Round
United States, France, Switzerland

Portfolio highlights

Pipe — Get up to the full annual value of your booked monthly and quarterly contracts. Scale your business without dilution or debt.
Cache — Biomolecules are the next bits of the 21st century. So we're developing the first wet operating system for storing, accessing, and computing biomolecules at scale to make them widely accessible and useful. We're enabling the storage and access to the whole data universe—digital and biological—forever so that we don't have to deleteor dispose of anything ever again.
Renaissance Fusion — Renaissance Fusion is a high-temperature superconductor and stellarator company.

Benjamin Kong is a Canadian investor backing early-stage transformative startups in Space, Biotech, Life Sciences, AI, Longevity, and Blockchain. He started investing in 2014 and has since funded over 50 startups and 3 VC funds. Recent early stage investments include Luminous Computing, Orbit Fab, Relativity Space, Swarm, TransAstra, RadianAerospace, Volumetric, OISIN, OncoSenX, Aegis BioDefense, Excision Biotherapeutics, MAIA Biotechnology, Ashvattha Therapeutics, ZenGo, Coinbase, Algorand, Oasis Labs, Arweave.

Investment focus

Blockchain, Biotechnology, Cryptocurrency
Seed, Pre-Seed, Funding Round
United States, Israel, United Kingdom

Portfolio highlights

Radian — Radian Aerospace (Radian) is disrupting the aerospace industry with a next generation aerospace vehicle that is the world’s first fully reusable horizontal takeoff and landing, single-stage to orbit spaceplane, delivering people and light cargo to low earth orbit (LEO) and multiple terrestrial destinations with aircraft-like operations.
Volumetric — Advanced materials and 3D biofabrication.
Excision BioTherapeutics — Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Franklin Berger has served as a member of our board of directors since September 2010. Franklin Berger is a consultant to biotechnology industry participants, including major biopharmaceutical firms, mid-capitalization biotechnology companies, specialist asset managers and venture capital companies, providing business development, strategicadvisory, financing, partnering, and royalty acquisition advice. Franklin Berger is also a biotechnology industry analyst with over 25 years of experience in capital markets and financial analysis. Franklin Berger worked at Sectoral Asset Management as a founder of the small-cap focused NEMO Fund from 2007 through June 2008.From May 1998 to March 2003, he served at J.P. Morgan Securities, most recently as Managing Director, Equity Research and Senior Biotechnology Analyst. In this position, he initiated coverage of 26 biotechnology companies and was responsible for technical, scientific and clinical due diligence as well as company selection.Franklin began his career as a sell-side analyst at Josephthal & Co. in 1991, subsequently moving to Salomon Smith Barney in 1997 serving as Director, Equity Research and Senior Biotechnology Analyst. Franklin currently serves on the board of directors of three biotechnology companies: Five Prime Therapeutics, Inc., Immune Design Corp. and Bellus Health, Inc. Previous public company board service included 11 years with Seattle Genetics, Inc., 7 years with VaxGen, Inc. and Aurinia Pharmaceuticals Inc. (previously Isotechnika Pharma Inc.), based in Canada. He also serves or has served on biotech company boards of directors including iTherX Pharma, Inc., Caprion Proteomics Inc. and ViroChem Pharma, Inc. (purchased by Vertex Pharmaceuticals, Inc. for $400 million in 2009). Franklin has led multiple M&A analyses resulting in greater than $1 billion in transaction value.. Franklin received a B.A. in International Relations and an M.A. in International Economics both from Johns Hopkins University and an M.B.A. from the Harvard Business School.

Investment focus

Health Care, Therapeutics, Biotechnology
Seed, Series A, Series B
United States

Portfolio highlights

MindRhythm — MindRhythm is a medical device company focused on applying novel biometrics to stroke and concussion patients to improve diagnosis, triage and management. Their proprietary monitoring devices and communication platform provide novel and real-time visibility to life-threatening situations prehospital and in the operating room, allowing clinicians tointervene earlier and with better precision to prevent brain damage.
Auron Therapeutics — A differentiated approach to cure cancer.
Amphivena Therapeutics — Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics. Its Amphivena ReSTORE platform provides dual-action biologics that relieve immune suppression and activate T cell effector function in cancer patients. The platform design integrates elements of avidity, target selectivity, andenhanced safety within a single molecule. It is also can be engineered with additional solid tumor targeting modalities to add functionality such as directed tumor cell killing.It was founded in 2012 and is headquartered in South San Francisco, California.

Kirill is the CEO and Founder of Enki, a tech-enabled skills training company.Previously, Kirill cofounded Emerging Travel, a leading online travel agency; and Quid, an intelligence tool for strategy teams. Both companies have over $40M annual net revenue each.Kirill is an Oxford University alum where he graduated with a double first inMathematics and as the #1 UK Graduate of the Year.

Investment focus

Health Care, Apps, Mobile
Seed, Angel
United States, United Kingdom

Portfolio highlights

Calm — Relax with Calm, a simple mindfulness meditation app that brings clarity and peace of mind into your life
Togethera — We're bringing the world’s families closer together by providing a private, simple place to share, that’s easily accessible by grandparents and children, on phones, tablets and computers.
Share Practice — Share Practice helps doctors identify and understand the most effective clinical treatments based on the success of other doctors.

Tim Kendall is the Co-Founder of Moment.He attend to the Stanford University Graduate School of Business in 2004.

Investment focus

Health Care, Artificial Intelligence, E-Commerce
Seed, Series A, Angel
United States

Portfolio highlights

Pendulum — Improve glucose control, metabolic health, gut function, and support a healthy weight. The only brand with live Akkermansia. Pendulum Metabolic Daily | Optimizes metabolism Pendulum Akkermansia | For gut health Pendulum Glucose Control | For A1C management Pendulum Butyricum | For occasional gut discomfort
Alto Neuroscience — Alto Neuroscience is a clinical-stage biopharmaceutical company that integrates the biology of the patient into drug development to improve the lives of people with mental health conditions. Through its AI-enabled biomarker platform, Alto Neuroscience combines rich sources of information on patients’ brain activity and behavior to rapidly develophighly-effective medicines for targeted populations. Alto Neuroscience aims to replace today's trial-and-error clinical approach by aligning the right Alto drug with the right patient, redefining psychiatry at a time when the world needs it most.
Checkmate — Never miss a deal.